UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 58

Sortiert nach

The Flux Operator [version 1; peer review: awaiting peer review]

F1000 research, 2024-01, Vol.13, p.203

2024

Volltextzugriff (PDF)

Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population

PloS one, 2017-09, Vol.12 (9), p.e0184492-e0184492

2017

Volltextzugriff (PDF)

Correction: Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population

PloS one, 2018-05, Vol.13 (5), p.e0197138-e0197138

2018

Volltextzugriff (PDF)

Early 3‐month treatment with comprehensive physical therapy program restores continence in urinary incontinence patients after radical prostatectomy: A randomized controlled trial

Neurourology and urodynamics, 2020-06, Vol.39 (5), p.1529-1537

2020

Volltextzugriff (PDF)

The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy

The Journal of urology, 2015-06, Vol.193 (6), p.1963

2015

Volltextzugriff (PDF)

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model

The Journal of urology, 2009-11, Vol.182 (5), p.2195

2009

Volltextzugriff (PDF)

Long‐term outcome of adjustable transobturator male system for stress urinary incontinence in the Iberian multicentre study

Neurourology and urodynamics, 2020-08, Vol.39 (6), p.1737-1745

2020

Volltextzugriff (PDF)

Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study

World journal of urology, 2019-10, Vol.37 (10), p.2189-2197

2019

Volltextzugriff (PDF)

Treatment of male stress urinary incontinence with the adjustable transobturator male system: Outcomes of a multi-center Iberian study

Neurourology and urodynamics, 2018-04, Vol.37 (4), p.1458-1466

2018

Volltextzugriff (PDF)

A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C

European urology, 2007-11, Vol.52 (5), p.1398-1406

2007

Volltextzugriff (PDF)

Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions

Enfermedades infecciosas y microbiologia clinica, 2017-05, Vol.35 (5), p.273-277

2017

Volltextzugriff (PDF)

Síndrome de Wünderlich: importancia del diagnóstico por imagen

Actas urologicas españolas, 2009-09, Vol.33 (8), p.917-919

2009

Volltextzugriff (PDF)

Renal colic during pregnancy: Diagnostic and therapeutic aspects. Literature review

Central European journal of urology, 2017-01, Vol.70 (1), p.93-100

2017

Volltextzugriff (PDF)

Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions

Enfermedades infecciosas y microbiologia clinica (English ed.), 2017-05, Vol.35 (5), p.273-277

2017

Volltextzugriff (PDF)

Complications of polypropylene mesh for the treatment of female pelvic floor disorders

Archivos españoles de urología, 2011-09, Vol.64 (7), p.620

2011

Volltextzugriff (PDF)

Re: Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-Invasive Bladder Cancer in Intermediate-and High-Risk Patients: Final Outcome of CUETO 93009, A Randomized Prospective Trial

Journal of urological surgery, 2015-03, Vol.2 (1), p.40-40

2015

Volltextzugriff (PDF)

Tratamiento del cáncer de próstata con intención curativa según la edad y la esperanza de vida

Medicina clínica, 2005-06, Vol.125 (4), p.140-142

Ojea Calvo, Antonio

2005

Volltextzugriff (PDF)

Treatment with curative intention of prostate cancer depending on age and life expectancy

Medicina clínica, 2005-06, Vol.125 (4), p.140-142

Ojea Calvo, Antonio

2005

Volltextzugriff (PDF)

Cáncer de próstata, terapia antiandrogénica y riesgo cardiovascular

Atención primaria, 2011-04, Vol.43 (4), p.197-201

2011

Volltextzugriff (PDF)

Cáncer de próstata, terapia antiandrogénica y riesgo cardiovascular

Atención primaria, 2011-04, Vol.43 (4), p.197-201

2011

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(53)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Humans
(28)
Life Sciences & Biomedicine
(26)
Male
(23)
Middle Aged
(21)
Aged
(17)
Female
(17)
Urology & Nephrology
(13)
Adult
(12)
Infectious Diseases
(11)
Urology
(11)
Aged, 80 And Over
(9)
Biological And Medical Sciences
(7)
Medical Sciences
(7)
Multivariate Analysis
(7)
Retrospective Studies
(7)
Risk Factors
(7)
Treatment Outcome
(7)
Urinary Bladder Neoplasms - Pathology
(6)
Disease Progression
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Flux Operator [version 1; peer review: awaiting peer review]

Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population

Correction: Lifestyle factors and oncogenic papillomavirus infection in a high-risk male population

Early 3‐month treatment with comprehensive physical therapy program restores continence in urinary incontinence patients after radical prostatectomy: A randomized controlled trial

The metabolic syndrome and its components in patients with prostate cancer on androgen deprivation therapy

Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model

The EORTC Tables Overestimate the Risk of Recurrence and Progression in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: External Validation of the EORTC Risk Tables

Prognostic Factors in Patients with Non–Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

Long‐term outcome of adjustable transobturator male system for stress urinary incontinence in the Iberian multicentre study

Patient satisfaction with adjustable transobturator male system in the Iberian multicenter study

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial

Treatment of male stress urinary incontinence with the adjustable transobturator male system: Outcomes of a multi-center Iberian study

A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C

Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions

Síndrome de Wünderlich: importancia del diagnóstico por imagen

Renal colic during pregnancy: Diagnostic and therapeutic aspects. Literature review

Prevalence and concordance of high-risk papillomavirus infection in male sexual partners of women diagnosed with high grade cervical lesions

Complications of polypropylene mesh for the treatment of female pelvic floor disorders

Re: Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guerin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-Invasive Bladder Cancer in Intermediate-and High-Risk Patients: Final Outcome of CUETO 93009, A Randomized Prospective Trial

Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin : Multivariate Analysis of Data from Four Randomized CUETO Trials. Commentary

Tratamiento del cáncer de próstata con intención curativa según la edad y la esperanza de vida

Treatment with curative intention of prostate cancer depending on age and life expectancy

Cáncer de próstata, terapia antiandrogénica y riesgo cardiovascular

Cáncer de próstata, terapia antiandrogénica y riesgo cardiovascular

Suchergebnisse filtern